Isolated dimeric fibroblast activation protein alpha, and uses thereof

US5767242A · kind A · utility

Assignees

• Boehringer Ingelheim Int'l. GmbH · DE
• LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

• Rainer Zimmermann · Mittelbiberach, DE
• John Park · Warthausen, DE
• Wolfgang J. Rettig · Biberach, DE
• Lloyd J. Old · New York, US

Key dates

• Filing date: Mar 18, 1996
• Grant date: Jun 16, 1998
• Expiry date: Mar 18, 2016

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2799/026
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The invention involves dimeric forms of the protein known as fibroblast activation protein alpha, or "FAP.alpha." and its uses.